ask="1.16"
ask_size="2500"
average_daily_volume="303110"
bid="0.60"
bid_size="200"
book_value="0.12"
change="+0.01"
change_from_200_day_moving_average="-0.27"
change_from_50_day_moving_average="0.12"
change_from_52_week_high="-1.98"
change_From_52_week_low="0.58"
change_in_percent="+0.94%"
close="1.07"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.83"
ebitda="-21.56M"
eps_estimate_current_year="-0.81"
eps_estimate_next_quarter="-0.18"
eps_estimate_next_year="-0.87"
ex_dividend_date="N/A"
float_shares="21600000"
high="1.11"
high_52_weeks="3.05"
last_trade_date="1/5/2017"
last_trade_price="1.07"
last_trade_size="100"
last_trade_time="3:55pm"
low="1.03"
low_52_weeks="0.49"
market_capitalization="31.45M"
moving_average_200_day="1.34"
moving_average_50_day="0.95"
name="Galectin Therapeutics Inc."
notes="N/A"
one_year_target_price="1.12"
open="1.05"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-20.22%"
percent_change_from_50_day_moving_average="+12.67%"
percent_change_from_52_week_high="-64.92%"
percent_change_from_52_week_low="+118.37%"
previous_close="1.06"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="8.48"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="29396000"
short_ratio="6.20"
stock_exchange="NCM"
symbol="GALT"
volume="170754"
weeks_range_52="0.49 - 3.05"
